Imatinib mesylate effect on bone marrow hematopoietic cells of chronic myeloid leukemia patients - - GEO DataSets

Summary

Format

Summary
Summary (text)
Unique Identifier List

Send to:

Choose Destination

File
Clipboard
Collections

Links from GEO Profiles

Imatinib mesylate effect on bone marrow hematopoietic cells of chronic myeloid leukemia patients

Analysis of bone marrow hematopoietic cells in chronic myeloid leukemia (CML) patients one month after imatinib mesylate (IM) therapy. CML is caused by expression of the BCR/ABL fusion oncogene. Results provide insight into the molecular consequences of IM blockade of oncoprotein Bcr-Abl in CML.

Organism:: Homo sapiens

Type:: Expression profiling by array, transformed count, 10 age, 10 gender, 10 individual, 3 protocol sets

Platform:: GPL570
Series:: GSE33075
27 Samples

Download data: CEL

DataSet

Accession:: GDS4869

ID:: 4869

Supplemental Content

GEO DataSets

Functional Genomics Studies

Result Filters

Send to:

Links from GEO Profiles

Supplemental Content

Related information

Important Links

Recent activity